Latest Breaking News On - Xavier duportet - Page 1 : comparemela.com

Eligo Bioscience forges ahead with new acne treatment after $30 million investment

Eligo Bioscience, a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.

Eligo Bioscience Raises $30M in Series B Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines

Eligo Bioscience Patents Genetic Engineering of Cutibacterium acnes for Skin Therapies

The patent supports therapeutic interventions in serious skin disorders. This work provides opportunities to leverage the skin s immune system for oncological, vaccination or desensitization applications.

Eligo's EB003 receives FDA Orphan Drug Designation

Eligo Bioscience has received Orphan Drug Designation (ODD) and Rare Pediatric Disease (RPD) designation from the FDA for EB003.